The Swiss medical device firm posted a 1.4 million CHF decline in gross profit despite a higher margin of 37.8%.
Medmix AG reported first-half revenue of CHF214.4 million, with gross profit decreasing by CHF1.4 million to CHF81.1 million. The decline was attributed to lower group revenues during the period.
Despite the revenue drop, the company achieved a gross profit margin of 37.8%, up from 36.6% in the same period last year. Adjusted EBITDA fell by CHF1.3 million to CHF43.5 million.
No immediate market reaction was disclosed in the release.